Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/17/2012EP2510002A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510001A1 Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
10/17/2012EP2510000A1 Anti-inflammatory antibodies and uses therefor
10/17/2012EP2509999A1 Anti-inflammatory agents directed against citrullinated epitopes
10/17/2012EP2509998A1 Antibody that binds to h-1 parvovirus
10/17/2012EP2509997A1 Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
10/17/2012EP2509630A1 Delivery system for cytotoxic drugs by bispecific antibody pretargeting
10/17/2012EP2509629A1 Dock-and-lock (dnl) complexes for delivery of interference rna
10/17/2012EP2509626A1 Anti-vegf-c antibodies and methods using same
10/17/2012CN1771338B High affinity anti-human IgE antibodies
10/17/2012CN102741404A Human artificial chromosome vector
10/17/2012CN102741295A Antigen presenting cell targeted anti-viral vaccines
10/17/2012CN102741294A Antibodies for treating and diagnosing tumors expressing SLC34A2 (TAT211 = SEQID 2)
10/17/2012CN102741293A Affinity-matured humanized anti cea monoclonal antibodies
10/17/2012CN102741292A A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma
10/17/2012CN102741291A Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012CN102741290A Monoclonal antibodies that bind B7H6 and uses thereof
10/17/2012CN102741289A Antibodies specific for claudin 6 (cldn6)
10/17/2012CN102741288A Therapeutic dll4 binding proteins
10/17/2012CN102741287A Antibody molecules having specificity for human OX40
10/17/2012CN102741286A Anti human RANKL monoclonal antibodies developed by PAE technology and uses thereof
10/17/2012CN102741285A Human IL-23 antigen binding proteins
10/17/2012CN102741284A Human antibodies to human angiopoietin-like protein 4
10/17/2012CN102741283A Anti-C5a binding moieties with high blocking activity
10/17/2012CN102741282A Antibodies directed against the transferrin receptor and uses thereof for immunotherapy of iron-dependent tumours
10/17/2012CN102741281A Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum
10/17/2012CN102741279A B7-h4 fusion proteins and methods of use thereof
10/17/2012CN102741277A IFN[gamma]inhibitors in the treatment of motoneuron diseases
10/17/2012CN102741272A Peptides inhibiting adhesion of aspergillus fumigatus to cornea
10/17/2012CN102741260A New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
10/17/2012CN102740889A Therapies for preventing or suppressing clostridium difficile infection
10/17/2012CN102740886A Use of vap-1 inhibitors for treating fibrotic conditions
10/17/2012CN102740885A Treatment of cancer involving mutated kras or braf genes
10/17/2012CN102740884A Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
10/17/2012CN102732974A Method for constructing phage antibody libraries and CD6-resisting antibody obtained by screening by using phage antibody libraries
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732533A Vaccine produced by using Cryptocaryon irritans immbolization antigen to complement deoxyribonucleic acid, and production method and application thereof
10/17/2012CN102732441A Application of Pseudomonas aeruginosa polyclonal antibody during salmonella separation process
10/17/2012CN102731659A 6*His-C99recombinant protein, and preparation method and application thereof
10/17/2012CN102731656A Recombinant anti-OPN monoclonal antibody and preparation method and use thereof
10/17/2012CN102731655A Specific monoclonal antibodies of coding regions and constant regions of goose immunoglobulin, and applications thereof
10/17/2012CN102731654A High affinity antibodies against hmgb1 and methods of use thereof
10/17/2012CN102731653A Anti-phosphorylation Oct4 protein antibody and its application
10/17/2012CN102731652A Preparation method of nanoliposome anti-bovine mastitis drug-resistant pathogenic bacteria specific composite IgY and its preparation
10/17/2012CN102731651A Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
10/17/2012CN102731650A Monoclonal antibody for inhibiting virus from infecting human T lymphocyte
10/17/2012CN102731649A Chicken-derived single-chain antibody against Newcastle disease virus, its preparation method and application
10/17/2012CN102731617A Hantaan virus glucoprotein specific T cell epitope peptide and application thereof
10/17/2012CN102731616A Tetanus-toxin-neutralizing B cell epitope peptide and application thereof
10/17/2012CN102731615A Detection reagent and detection method for PRRSV
10/17/2012CN102731611A Leptomycin derivatives
10/17/2012CN102329378B HCV (hepatitis C virus) core antigen and antibody thereof as well as hybridoma cell lines secreting antibody
10/17/2012CN102041265B Immunoassay reagent for assaying influenza A H1N1 virus antigen
10/17/2012CN101967189B RBP4 (Retinol Binding Protein 4) monoclonal antibody and hybridoma cells thereof as well as preparation method and applications thereof
10/17/2012CN101896502B A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof
10/17/2012CN101880324B Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
10/17/2012CN101287760B Anti-IL13 human antibodies
10/17/2012CN101115772B Cytotoxic antibody directed against type-B lymphoid haematopoietic prolifeeations
10/16/2012US8288520 Fast results hybrid capture assay and system
10/16/2012US8288518 Rearranged squamous cell carcinoma antigen genes
10/16/2012US8288510 Isolated peptides having phospholipase inhibitory activity
10/16/2012US8288509 Therapeutic agent for infections, and treatment method using the same
10/16/2012US8288336 Treatment of subarachnoid hemorrhage with ApoE analogs
10/16/2012US8288335 ApoE analogs and methods for their use
10/16/2012US8288322 Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012US8287874 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012US8287871 Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodies
10/16/2012US8287869 Method of treating inflammatory disease by inhibition of IL-17 production
10/16/2012US8287868 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012US8287863 Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen
10/16/2012US8287860 Immunogen and antivenom against violin spider venom
10/16/2012CA2545714C Neutralizing human antibodies to anthrax toxin generated by recall technology
10/16/2012CA2516028C Conjugates comprising a cancer targeting molecule linked to a liver-expressed chemokine
10/16/2012CA2469492C Diagnostic methods for protein profiling
10/16/2012CA2455271C Use of musk autoantibodies
10/16/2012CA2451847C A novel engineered superantigen for human therapy
10/16/2012CA2412498C Non-human animal models of tolerance to hepatitis c virus immunogenes
10/16/2012CA2411392C Tetrameric antibody complexes for blocking non-specific binding of antigens
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2329829C Protein purification by ion exchange chromatography
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012139106A2 Herpes simplex virus
10/11/2012WO2012139086A2 Single chain antibodies for photosynthetic microorganisms and methods of use
10/11/2012WO2012139069A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012WO2012139051A2 Autoantibody biomarkers for iga nephropathy
10/11/2012WO2012139045A1 Methods and compositions for normalization of tumor vasculature by inhibition of loxl2
10/11/2012WO2012138997A1 Novel egfr binding proteins
10/11/2012WO2012138975A1 Anti-fgfr4 antibodies and methods of use
10/11/2012WO2012138510A1 Antibodies that bind tgf-alpha and epiregulin
10/11/2012WO2012138475A1 Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
10/11/2012WO2012138102A2 Dlk1-specific human antibodies and pharmaceutical composition containing same
10/11/2012WO2012138100A2 Activin receptor type ii b inhibitors comprising dlk1 extracellular water-soluble domain
10/11/2012WO2012137993A1 Antibodies against angiopoietins 1 and 2, and their use
10/11/2012WO2012137896A1 Method for producing sheet-like pancreatic islet
10/11/2012WO2012137676A1 Novel anti-human il-23 receptor antibody
10/11/2012WO2012136790A1 Compositions comprising fusion proteins or conjugates with an improved half -life
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 1494